Trend analysis of carbapenem-resistant Gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era: an extra challenge for healthcare institutions
Nenhuma Miniatura disponível
Data
2022-02-01
Autores
de Carvalho Hessel Dias, V. M.
Tuon, F.
de Jesus Capelo, P.
Telles, J. P.
Fortaleza, C. M.C.B. [UNESP]
Pellegrino Baena, C.
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
The incidence density trend of the carbapenem-resistant Gram-negative bacteria was analysed in device-associated infections and antimicrobial consumption in 99 critical care facilities in a low/middle-income country, between January 2019 and December 2020. Carbapenem-resistant Acinetobacter baumannii (CRAB) per 1000 patient-days increased in 2020 and this finding had a strong positive correlation with the incidence density of COVID-19 by the Spearman test. Polymyxin consumption also increased in 2020 but without significant correlation with CRAB or COVID-19 incidence density, presumably due to empirical and untargeted prescribing as a consequence of concern about CRAB infections. These findings are a warning to infection control programmes and antimicrobial stewardship.
Descrição
Palavras-chave
Acinetobacter baumannii, Antimicrobial drug resistance, Carbapenems, COVID-19, Healthcare-associated infections, Polymyxins
Como citar
Journal of Hospital Infection, v. 120, p. 43-47.